An immune and epithelial–mesenchymal transition-related risk model and immunotherapy strategy for grade II and III gliomas

Overview of attention for article published in Frontiers in Genetics, January 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,640 followers.

An immune and epithelial-mesenchymal transition-related risk model and immunotherapy strategy for grade II and III gliomas https://t.co/3aL2sMpvLf https://t.co/EUsFbbOjaQ

26 Feb 2023

Reply Repost Favourite

New Research: An immune and epithelial–mesenchymal transition-related risk model and immunotherapy strategy for grade II and III gliomas: Grade II and III gliomas are heterogeneous and aggressive diseases. More efficient prognosis models and… https://t.co/

04 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.